ImevaX

ImevaX

ImevaX

ImevaX is a startup project developing novel vaccination strategies against globally relevant pathogens by targeting essential bacterial factors..
Founded
2014
Raised
$9.7M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
Undisclosed amount
Venture capital (Series A) - 2015
€7,500,000
Venture capital (Series A) - 2014
Wellington Partners Santo Venture Capital EMBL Ventures +1
Team Size
1–10
Employees
Location
Headquarters

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when ImevaX makes some noise.